3-Methylmethcathinone (3-MMC), also known as metaphedrone, is a synthetic cathinone and positional isomer of the widely known party drug mephedrone (4-MMC). The two compounds share an identical molecular formula and differ only in the position of the methyl group on the phenyl ring — at the meta position (3-) rather than the para position (4-) . 3-MMC emerged on the European recreational drug market primarily as a direct consequence of mephedrone's prohibition, filling the regulatory gap left when 4-MMC was banned across the European Union beginning in 2010.
As a substrate-type monoamine releasing agent, 3-MMC promotes the release of dopamine, norepinephrine, and serotonin from presynaptic terminals, producing a combination of stimulant euphoria and mild empathogenic warmth. Notably, its pharmacological profile skews more dopaminergic than mephedrone, giving it stronger amphetamine-like stimulant properties and a more compulsive redosing pattern .
3-MMC became particularly prevalent in the Netherlands, where it was sold legally as a "research chemical" until it was placed on List II of the Opium Act in October 2021 . Despite this ban, 3-MMC use continued to rise — treatment admissions for problematic 3-MMC use in the Netherlands increased tenfold from 33 in 2021 to 330 in 2023, reflecting its deeply entrenched position in European nightlife culture .
References
Simmler LD et al. Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology. 2013;79:152-160. Luethi D et al. Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology. 2018;134(Pt A):4-12. NL Times. The Netherlands restricts designer drug 3-MMC. May 27, 2021. EUDA. Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands. European Union Drugs Agency. 2025.
Safety at a Glance
High Risk- Serotonin syndrome risk
- Austria: 3-MMC is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).
- Toxicity: Cardiovascular Toxicity 3-MMC produces dose-dependent cardiovascular stimulation driven primarily by potent norepinep...
- Dangerous with: 25x-NBOH, 25x-NBOMe, Atropa belladonna, Datura, MDMA (+3 more)
- Overdose risk: Stimulant overdose from 3-MMC is a medical emergency primarily involving cardiovascular and neuro...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
insufflated
intravenous
oral
Duration
insufflated
Total: 2.5 hrs – 4.5 hrsintravenous
Total: 2 hrs – 4 hrsoral
Total: 4 hrs – 6 hrsHow It Feels
The onset of 3-MMC is rapid and unmistakable. Within fifteen to thirty minutes of oral ingestion, a surging warmth floods upward through the torso and into the head. The heart accelerates, the skin flushes, and a wave of euphoria breaks over the mind with a force that announces this is no subtle compound. There is an immediate desire to talk, to move, to touch, and to be touched. The world suddenly feels brighter, warmer, and filled with people worth knowing.
As the experience builds to its peak over the next thirty to sixty minutes, 3-MMC reveals its dual nature as both stimulant and empathogen. The euphoria is rich and multi-layered: a dopaminergic confidence and energy braided with a serotonergic warmth and emotional openness. Conversation becomes effortless and deeply satisfying. Social inhibitions dissolve, and there is an almost magnetic pull toward connection and closeness. Touch takes on an extraordinary quality, soft surfaces feel luxurious, skin-to-skin contact radiates pleasure. Music sounds vivid and physically resonant, each beat landing in the body as much as the ears. The jaw clenches hard, the pupils dilate widely, and the body buzzes with a restless, pleasurable energy.
At the peak, 3-MMC is intensely rewarding, and this is precisely the source of its risk. The euphoria is potent enough to create a powerful desire for more as soon as it begins to wane. The compulsive redosing urge is among the strongest of any cathinone. Each redose brings diminishing returns but the same insistent craving. Physically, heart rate and blood pressure are significantly elevated, body temperature runs high, sweating is common, and the jaw tension can become genuinely painful. Despite these warning signals, the subjective experience remains so pleasurable that they are easily dismissed.
The comedown arrives within two to three hours and is proportional to the height of the peak. As the euphoria recedes, it is replaced by a restless flatness and a gnawing dissatisfaction. Energy drains away, mood drops, and a heavy tiredness settles over the body. If redosing has extended the session, the comedown intensifies accordingly: irritability, anxiety, jaw soreness, and an oppressive fatigue that resists sleep even as it demands it. The following day often carries a pronounced serotonergic hangover, a dull, joyless quality that reflects the neurochemical debt incurred during those brief, brilliant hours.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(25)
- Abnormal heartbeat— Abnormal heartbeat (arrhythmia) is any deviation from the heart's normal rhythm — including beats th...
- Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
- Bodily control enhancement— Bodily control enhancement is the subjective feeling of improved physical precision, coordination, a...
- Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
- Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
- Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
- Increased blood pressure— Increased blood pressure (hypertension) is an elevation of arterial pressure above the normal 120/80...
- Increased bodily temperature— Increased bodily temperature (hyperthermia) is an elevation of core body temperature above the norma...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Nystagmus— Rapid, involuntary oscillating movements of the eyes that cause vision to vibrate and blur, often ma...
- Orgasm suppression— Orgasm suppression (anorgasmia) is the difficulty or complete inability to achieve orgasm despite ad...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Respiratory depression— A dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions ...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
- Serotonin syndrome— Serotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activit...
- Stamina enhancement— Stamina enhancement is an increase in one's ability to sustain physical and mental exertion over ext...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
- Temperature regulation disruption— Impaired thermoregulation causing unpredictable fluctuations between feeling hot and cold, with risk...
- Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...
- Vibrating vision— Vibrating vision is the subjective experience of the visual field rapidly oscillating or shaking due...
Tactile(2)
- Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...
- Tactile hallucination— Tactile hallucinations are convincing physical sensations experienced without any corresponding exte...
Cognitive & Perceptual Effects
Visual(5)
- Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
- Double vision— The visual experience of seeing a single object as two separate, overlapping images, similar to cros...
- Pattern recognition enhancement— An increased ability and tendency to perceive meaningful patterns, faces, and images within ambiguou...
- Symmetrical texture repetition— Textures appear to mirror and tessellate across surfaces in intricate, self-similar symmetrical patt...
- Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
Cognitive(22)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Anxiety suppression— A partial to complete suppression of anxiety and general unease, producing a calm, relaxed mental st...
- Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
- Cognitive fatigue— Mental exhaustion and difficulty sustaining thought after intense cognitive experiences, common duri...
- Compulsive redosing— An overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maint...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Delirium— Delirium is a serious and potentially dangerous state of acute mental confusion involving disorienta...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
- Disinhibition— A marked reduction in social inhibitions, self-consciousness, and behavioral restraint that manifest...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Irritability— Irritability is a sustained state of emotional reactivity in which the threshold for annoyance, frus...
- Mania— Abnormally elevated mood, energy, and activity with impulsive behavior and grandiosity, associated w...
- Motivation enhancement— A heightened sense of drive, ambition, and willingness to accomplish tasks, making productive effort...
- Motivation suppression— Motivation suppression is a state of diminished drive and willingness to engage in goal-directed beh...
- Panic attack— A panic attack is a discrete episode of acute, overwhelming fear or terror that arises suddenly and ...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Thought deceleration— The experience of thoughts occurring at a markedly reduced pace, as if the mind has been placed into...
- Thought loops— Becoming trapped in a repeating cycle of thoughts, actions, and emotions that loops every few second...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Auditory(2)
- Auditory enhancement— Auditory enhancement is a heightened sensitivity and appreciation of sound in which music, voices, a...
- Auditory hallucination— Auditory hallucination is the perception of sounds that have no external source — hearing music, voi...
Pharmacology
Monoamine Transporter Activity
3-MMC acts as a substrate-type monoamine releasing agent, entering presynaptic neurons through monoamine transporters and triggering non-exocytotic neurotransmitter release. At the molecular level, 3-MMC potently inhibits the norepinephrine transporter (NET) and dopamine transporter (DAT), with relatively weaker activity at the serotonin transporter (SERT) . This transporter selectivity profile represents a critical pharmacological distinction from its isomer mephedrone (4-MMC): while mephedrone inhibits SERT more potently than DAT (producing an MDMA-like, empathogenic character),3-MMC inhibits DAT more potently than SERT, producing stronger amphetamine-like psychostimulant properties .
Comparison with Mephedrone (4-MMC)
The positional shift of the methyl group from para (4-MMC) to meta (3-MMC) fundamentally alters the compound's pharmacological character. Mephedrone analogs generally potently inhibit NET and, with the exception of 3-MMC, inhibit SERT more potently than DAT . This means 3-MMC leans more toward the stimulant end of the empathogen-stimulant spectrum, with greater dopaminergic drive producing more intense euphoria but also greater addiction liability and compulsive redosing potential.
Rapid Onset and Short Duration
3-MMC is characterized by rapid onset (15-30 minutes orally, near-instantaneous insufflated) andshort duration of peak effects (1-3 hours), a pharmacokinetic profile that strongly drives compulsive redosing behavior . Users frequently describe an intense but brief euphoric peak followed by a rapid decline that produces powerful urges to re-administer. This pattern is pharmacologically analogous to crack cocaine's relationship to powder cocaine — the compressed time course amplifies both the subjective reward signal and the subsequent dysphoria, creating a powerful behavioral reinforcement loop.
Functional Effects
At the systems level, 3-MMC's potent NET inhibition is responsible for pronounced sympathomimetic stimulation — tachycardia, hypertension, pupil dilation, and peripheral vasoconstriction. The dopaminergic component drives reward, euphoria, and psychomotor activation, while the moderate serotonergic release contributes a warmth and prosociality that, while less pronounced than mephedrone or MDMA, distinguishes 3-MMC from pure dopaminergic stimulants .
References
Simmler LD et al. Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology. 2013;79:152-160. Luethi D et al. Pharmacological profile of mephedrone analogs and related NPS. Neuropharmacology. 2018;134(Pt A):4-12. Hondebrink L et al. 3-MMC poisonings: acute clinical toxicity and time trend 2013-2021 in the Netherlands. Ann Emerg Med. 2022;80(6):518-526. Eshleman AJ et al. Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol. 2013;85(12):1803-1815.
Detection Methods
Standard Immunoassay Screening
3-MMC is not specifically targeted by standard workplace or clinical immunoassay drug panels. However, its structural similarity to amphetamine and methamphetamine means it may triggerfalse-positive results on amphetamine-class immunoassays. The CEDIA Amphetamine/Ecstasy and EMIT d.a.u. Amphetamine Class assays have demonstrated the highest cross-reactivity toward synthetic cathinones and structurally related novel psychoactive substances . A positive screening result for amphetamines in a known cathinone user should be interpreted cautiously and always confirmed with a specific analytical method.
Confirmatory Analytical Methods
Definitive identification of 3-MMC requires GC-MS (gas chromatography-mass spectrometry) orLC-MS/MS (liquid chromatography-tandem mass spectrometry), which can unambiguously differentiate 3-MMC from its positional isomers 2-MMC and 4-MMC (mephedrone) based on unique fragmentation patterns and retention times . This isomer differentiation is forensically important, as the legal status of each positional isomer may differ across jurisdictions.
Detection Windows
Urine detection windows for 3-MMC and its metabolites are relatively short due to the compound's rapid metabolism, typically 24-72 hours following last use depending on dose, frequency, and individual metabolic factors. Blood detection windows are shorter, generally12-24 hours . Hair analysis can extend detection windows to weeks or months but requires specialized LC-MS/MS methods.
References
Ellefsen KN et al. Synthetic cathinone cross-reactivity in commercial immunoassays. Clin Chem. 2014;60(12):1510-1517. Shima N et al. Differentiation of synthetic cathinone isomers by GC-MS and LC-MS/MS. Forensic Toxicol. 2014;32(2):248-260. Dias da Silva D et al. Metaphedrone (3-methylmethcathinone): pharmacological, clinical, and toxicological profile. Medicina. 2024;60(3):466.
Interactions
| Substance | Status | Note |
|---|---|---|
| 25x-NBOH | Dangerous | — |
| 25x-NBOMe | Dangerous | — |
| Atropa belladonna | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Datura | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Diphenhydramine | Dangerous | Extreme cardiovascular strain from anticholinergic and stimulant effects combined |
| Harmala alkaloid | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| Peganum harmala | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| MDMA | Unsafe | — |
| 1,3-Butanediol | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25E-NBOH | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-2 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-21 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Alcohol | Uncertain | — |
| Dissociatives | Uncertain | — |
History
3-MMC is part of the stimulant class of psychoactive substances, which has a long and complex history spanning medical, military, occupational, and recreational use.
The modern history of stimulants begins with the isolation of ephedrine from traditional Chinese medicine in the 1880s, followed by the synthesis of amphetamine in 1887 and methamphetamine in 1893. Throughout the 20th century, stimulants were widely prescribed for conditions ranging from nasal congestion to depression, and were extensively used by militaries during World War II and the Korean War.
The recognition of abuse potential and adverse health effects led to increasing regulation from the 1960s onward, though stimulant medications remain among the most commonly prescribed treatments for ADHD and narcolepsy.
3-MMC exists within this broader context of stimulant pharmacology, with its specific history shaped by its date of development, clinical applications (if any), legal status, and pattern of use within different communities.
Harm Reduction
As with other stimulants, the chronic use of 3-extremely addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage. It is said that this compound is considerably more addictive than that of mephedrone.
Tolerance to many of the effects of 3-develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that,3 - 71 - 2 weeks to be back at baseline (in the absence of further consumption). 3-MMC presents cross-tolerance with Cross-all dopaminergic stimulants, meaning that after the consumption of 3-MMC all stimulants will have a reduced effect.
Serotonin syndrome risk
Austria: 3-MMC is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).
Brazil: Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344.
China: Since October 2015, 3-MMC has been banned (along with many other chemicals) in China. Due to this ban, many chemicals have become increasingly difficult to attain since the manufacturing was mainly done by Chinese chemical companies.
Czech Republic: 3-MMC is banned in the Czech Republic.
Germany: 3-MMC is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of December 13, 2014. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
Poland: 3-MMC is classified as a “II-P category drug” as of April 25th, 2024, making it
Toxicity & Safety
Cardiovascular Toxicity
3-MMC produces dose-dependent cardiovascular stimulation driven primarily by potent norepinephrine release. Clinical poisoning data from the Netherlands (184 cases between 2013 and mid-2021) documented tachycardia in 35% of cases, hypertension in 20%, and agitation in 19% of presentations . Severe cardiovascular events including chest pain, ECG abnormalities, and cardiac arrest have been reported. A fatal case documented clinical progression from tachycardia and hypertension through refractory hyperthermia (40.9 degrees Celsius), metabolic acidosis, rhabdomyolysis, and death after six days of intensive care .
Compulsive Redosing and Binge Patterns
The combination of 3-MMC's potent dopaminergic activity, rapid onset, and short duration creates a pharmacological profile highly conducive to compulsive redosing and binge consumption. Users commonly report consuming 0.5-2 grams in a single session through repeated administrations, with some binge episodes extending over 24-48 hours . This pattern dramatically amplifies all acute toxicity risks — cumulative sympathomimetic load on the cardiovascular system, progressive hyperthermia, dehydration, electrolyte derangement, and serotonin depletion. Treatment admissions for problematic 3-MMC use in the Netherlands increased tenfold between 2021 and 2023, underscoring the compound's addiction potential .
Serotonin-Related Risks
While less serotonergic than mephedrone, 3-MMC still releases sufficient serotonin to pose risk of serotonin syndrome when combined with MAOIs, SSRIs, or other serotonergic agents. Binge use also produces cumulative serotonin depletion, contributing to the profound "comedown" dysphoria and depressive symptoms reported by heavy users .
Long-Term Data Gap
Controlled long-term safety data for 3-MMC in humans is essentially nonexistent. The compound's relatively recent emergence means that chronic effects on cardiovascular health, cognitive function, and neurological integrity remain entirely uncharacterized.
References
Hondebrink L et al. 3-MMC poisonings: acute clinical toxicity and time trend 2013-2021 in the Netherlands. Ann Emerg Med. 2022;80(6):518-526. Adamowicz P, Tokarczyk B. A fatal case of 3-methylmethcathinone (3-MMC) poisoning. Forensic Sci Int. 2016;266:e5-e9. Dias da Silva D et al. Metaphedrone (3-methylmethcathinone): pharmacological, clinical, and toxicological profile. Medicina. 2024;60(3):466. EUDA. Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands. European Union Drugs Agency. 2025.
Addiction Potential
extremely addictive with a high potential for abuse
Overdose Information
Stimulant overdose from 3-MMC is a medical emergency primarily involving cardiovascular and neurological toxicity.
Signs of overdose: Extremely rapid or irregular heartbeat, chest pain, severe headache, dangerously elevated body temperature, seizures, agitation progressing to psychosis, confusion, and loss of consciousness.
Emergency response:
- Call emergency services immediately
- Keep the person cool (remove excess clothing, apply cool water)
- If seizures occur, protect the head and clear the area of hard objects
- If the person loses consciousness, place in recovery position
- Do not give the person more stimulants, caffeine, or depressants unless directed by medical professionals
Prevention: Pre-measure doses. Avoid redosing. Stay hydrated (but don't overhydrate). Take breaks from physical activity. Monitor heart rate if possible. Have someone present who can recognize warning signs.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Tolerance
| Full | develops with prolonged and repeated use |
| Half | 3 - 7 days |
| Zero | 1 - 2 weeks |
Cross-tolerances
Legal Status
Austria: 3-MMC is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).
Brazil: Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344.
China: Since October 2015, 3-MMC has been banned (along with many other chemicals) in China. Due to this ban, many chemicals have become increasingly difficult to attain since the manufacturing was mainly done by Chinese chemical companies.
Czech Republic: 3-MMC is banned in the Czech Republic.
Germany: 3-MMC is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of December 13, 2014. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
Poland: 3-MMC is classified as a “II-P category drug” as of April 25th, 2024, making it illegal.
Sweden: 3-MMC is classified as a narcotic substance.
Switzerland: 3-MMC can be considered a controlled substance as a defined derivative of Cathinone under Verzeichnis E point 1. It is legal when used for scientific or industrial use.
Turkey:** 3-MMC is a classed as drug and is illegal to possess, produce, supply, or import.
The Netherlands:** 3-MMC was classified as a Lijst 2 (softdrug) drug in October 2021, Since April 2024 the goverment classified it as a Lijst 1 on the Opiumwet, making it a harddrug.
United Kingdom: 3-MMC is a Class B drug in the United Kingdom as a result of the cathinone catch-all clause.
United States:** 3-MMC is not formally listed but is categorized by the DEA as a Schedule I Positional Isomer.
Responsible use
Designer drug
Substituted cathinone
Stimulants
Entactogens
Mephedrone (4-MMC)
3-MMC (Wikipedia)
3-MMC (Isomer Design)
Discussion
3-MMC (3-Methylmethcathinone) Megathread (v1) (Bluelight)
Experience Reports (1)
Tips (6)
Seizures have been reported with 3-MMC use. If you have a history of seizures or epilepsy, avoid this substance entirely. Stay hydrated and avoid overheating, as stimulant cathinones increase seizure risk in hot environments.
Do not combine 3-MMC with hexen (NEH) or other cathinones. Both are stimulants acting on similar pathways and combining them significantly increases cardiovascular strain, overheating risk, and serotonergic toxicity.
Test 3-MMC with appropriate reagent kits and fentanyl test strips. Stimulant supplies have increasingly been found contaminated with fentanyl, which has caused a surge in overdose deaths among stimulant users.
3-MMC is extremely caustic when insufflated and causes significant nasal damage. Oral dosing in a capsule is the recommended route. If using rectally, dissolve properly in water first and use small volumes to ensure consistent absorption.
Start low with 3-MMC and wait for full onset before redosing. Stimulant redosing extends duration and side effects more than it extends euphoria, while adding cardiovascular strain. Set a firm limit before you start.
Avoid binge patterns with 3-MMC. Sleep deprivation combined with stimulant use dramatically increases psychosis risk after 48+ hours awake. If you find yourself redosing to avoid the comedown, that is a major warning sign.
Community Discussions (2)
See Also
References (4)
- Amphetamine: new content for an old topic — Heal et al. Neuropsychopharmacology Reviews (2013)paper
- MDMA-assisted therapy for PTSD — Mithoefer et al. Psychopharmacology (2019)paper
- 3-MMC - TripSit Factsheet
TripSit factsheet for 3-MMC
tripsit - 3-MMC - Wikipedia
Wikipedia article on 3-MMC
wikipedia